Sartorius Corporation - - BioPharm International

ADVERTISEMENT

Sartorius Corporation

BioPharm International
Volume 18, Issue 12

Company Description



Sartorius specializes in the manufacture and support of separation and purification equipment in the pharmaceutical and biotech industries scaleable from R&D to pilot plant to production levels. This covers process, pilot and laboratory filtration systems for pharmaceuticals and biotech industries, including membrane and depth filter cartridges and capsules, fermentors and bioreactors, crossflow micro and ultrafiltration systems, life sciences laboratory devices and cell culture products, SS housings, filter integrity test equipment, filter and bag assemblies and disposable mixing technologies. Filter materials include non-protein binding cellulose acetate, polyethersulfone, nylon, polypropylene, PTFE, cellulose nitrate and other membranes utilized from the QC laboratory to high demanding process filtration applications.

Technical Services

Sartorius' technical facilities provide validation services which include product wet integrity testing, viability and bacterial challenge testing, and compatibility studies. We also cover analytical testing services which consists of extractables studies (TOC, NVR, RP-HPLC, FTIR and GC-MS), chemical compatibility, and adsorption studies. Sartorius Biotechnology Services Group uses actual product formulation to provide comprehensive testing and final reports that meet and exceed current regulatory requirements and industry standards.

Facilities



Sartorius AG, headquartered in Goettingen, Germany, is an international market and technology leader in biotechnology. Our $60 million production facilities, called Plant 2001, are setting global standards for high-quality manufacture of separation products. The facilities are designed according to our integrated cleanroom concept to meet current and future quality requirements of the biotech industry. Plant 2001 means state-of-the-art production, increased capacity, highly skilled and trained personnel, and an advanced organization to serve growing needs of the biotechnology industry. Sartorius operates six manufacturing facilities in Europe, North America, and Asia. Technical service, sales and product centers are located in 124 countries.

Major Products/Markets Served

Our filter products are critical components in the cGMP-regulated production processes of our customers in the biotechnology industry. Our expertise covers applications for biomolecular and bioseparations, concentration, purification, fermentation, and cell culture technology from R&D to process-scale applications. Our company's new facility represents a new dimension in membrane-filter production and fulfills current and anticipated future quality and hygiene requirements of the biotech industry.

Our Product Line Includes:

Biotechnology Division:

  • Complete range of scalable crossflow and cartridge filtration products for the biotechnology industry
  • Laboratory fermenters and bioreactors – benchtop to production scale – cell culture and bioprocess automation systems for Life sciences, bioscience, fermentation and cell culture markets
  • Life Sciences products for universities, public institutes and small biotech companies

Mechatronics Division:

  • Industrial and laboratory scales and balances
  • Top quality load cell and electronic weighing products for industrial, laboratory and precision weighing
  • Metal-detection equipment, belt weighers, Checkweighers for industrial and laboratory applications

SARTORIUS CORPORATION
131 Heartland Boulevard Edgewood, NY

TELEPHONE
800.368.7178 631.254.4249

FAX
631.254.4253

E-MAIL

WEB ADDRESS
http://www.sartorius.com/

EMPLOYEES
3,750 (430 in the US)

FOUNDED
1870

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here